The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D002375:Catalepsy / Q000139:chemically induced; D002746:Chlorpromazine / Q000494:pharmacology*; D003864:Depression, Chemical; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects; D013881:Thioridazine / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D008996:Monoamine Oxidase Inhibitors; D010293:Pargyline; D006220:Haloperidol; D001058:Apomorphine; D013881:Thioridazine; D009526:Nialamide; D003913:Dextroamphetamine; D002746:Chlorpromazine